Pictet Asset Management Portfolio holdings
AUM
$104B
1-Year Est. Return
22.23%
1 Year Est. Return
+22.23%
AUM
$98.3B
AUM Growth
+$8.28B
(+9.2%)
Holding
2,078
Top Buys
| 1 | +$251M | |
| 2 | +$238M | |
| 3 | +$206M | |
| 4 |
Dominion Energy
D
|
+$193M |
| 5 |
Spotify
SPOT
|
+$162M |
Top Sells
| 1 | +$213M | |
| 2 | +$188M | |
| 3 | +$185M | |
| 4 |
ANSS
Ansys
ANSS
|
+$185M |
| 5 |
INFA
Informatica
INFA
|
+$182M |
Sector Composition
| 1 | Technology | 34.74% |
| 2 | Industrials | 16.05% |
| 3 | Healthcare | 11.58% |
| 4 | Financials | 8.09% |
| 5 | Consumer Discretionary | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Bank of New York Mellon
BK
$79.5B
| $46.3M | 0.05% |
508,411
+12,542
|
|
||
327
Xenon Pharmaceuticals
XENE
$3.45B
| $46.2M | 0.05% |
1,474,449
-3,168
|
|
||
328
West Pharmaceutical
WST
$20.3B
| $46.1M | 0.05% |
210,502
+76,151
|
|
||
329
Duke Energy
DUK
$91.7B
| $46M | 0.05% |
389,923
+32,405
|
|
||
330
Truist Financial
TFC
$60.8B
| $45.9M | 0.05% |
1,068,840
+220,631
|
|
||
331
PNC Financial Services
PNC
$77.8B
| $45.8M | 0.05% |
245,834
+1,528
|
|
||
332
Oneok
OKE
$47.9B
| $45.8M | 0.05% |
561,059
+91,936
|
|
||
333
Altria Group
MO
$97.9B
| $45.7M | 0.05% |
779,860
+3,280
|
|
||
334
Summit Therapeutics
SMMT
$14B
| $45.6M | 0.05% |
2,163,873
-497,731
|
|
||
335
Paychex
PAYX
$40.2B
| $45.4M | 0.05% |
311,934
+31,437
|
|
||
336
Nuvalent
NUVL
$8.31B
| $45M | 0.05% |
589,832
+35,691
|
|
||
337
Ventas
VTR
$37.8B
| $44.7M | 0.05% |
708,268
-62,482
|
|
||
338
Bank of Montreal
BMO
$90.7B
| $44.5M | 0.05% |
402,737
+3,879
|
|
||
339
Travelers Companies
TRV
$63.1B
| $43.6M | 0.04% |
162,820
-4,610
|
|
||
340
Thomson Reuters
TRI
$59.4B
| $43.5M | 0.04% |
216,770
-153
|
|
||
341
iShares Core S&P 500 ETF
IVV
$734B
| $43.3M | 0.04% |
70,100
+14,300
|
|
||
342
Enbridge
ENB
$105B
| $43.3M | 0.04% |
955,814
+18,751
|
|
||
343
United Parcel Service
UPS
$80.4B
| $43.2M | 0.04% |
428,237
+13,492
|
|
||
344
Axsome Therapeutics
AXSM
$7.48B
| $43M | 0.04% |
411,850
+78,645
|
|
||
345
Colgate-Palmolive
CL
$62.6B
| $43M | 0.04% |
472,659
+5,873
|
|
||
346
Protagonist Therapeutics
PTGX
$5.47B
| $41.6M | 0.04% |
751,977
+456,384
|
|
||
347
Darling Ingredients
DAR
$5.78B
| $41.4M | 0.04% |
1,089,925
-89,550
|
|
||
348
Strategy Inc
MSTR
$53.5B
| $41.2M | 0.04% |
101,945
+18,568
|
|
||
349
TransDigm Group
TDG
$76.6B
| $40.7M | 0.04% |
26,792
+318
|
|
||
350
Arthur J. Gallagher & Co
AJG
$63B
| $40M | 0.04% |
125,099
+11,199
|
|